298 related articles for article (PubMed ID: 31618686)
41. [Antipsychotics in bipolar disorders].
Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
[TBL] [Abstract][Full Text] [Related]
42. Prioritization of candidate cancer drugs based on a drug functional similarity network constructed by integrating pathway activities and drug activities.
Di J; Zheng B; Kong Q; Jiang Y; Liu S; Yang Y; Han X; Sheng Y; Zhang Y; Cheng L; Han J
Mol Oncol; 2019 Oct; 13(10):2259-2277. PubMed ID: 31408580
[TBL] [Abstract][Full Text] [Related]
43. Pimozide Suppresses the Growth of Brain Tumors by Targeting STAT3-Mediated Autophagy.
Ranjan A; Kaushik I; Srivastava SK
Cells; 2020 Sep; 9(9):. PubMed ID: 32971907
[TBL] [Abstract][Full Text] [Related]
44. Repositioning of Anthelmintic Drugs for the Treatment of Cancers of the Digestive System.
Laudisi F; Marônek M; Di Grazia A; Monteleone G; Stolfi C
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32668817
[TBL] [Abstract][Full Text] [Related]
45. Targeting autophagy by antipsychotic phenothiazines: potential drug repurposing for cancer therapy.
Lopes RM; Souza ACS; Otręba M; Rzepecka-Stojko A; Tersariol ILS; Rodrigues T
Biochem Pharmacol; 2024 Apr; 222():116075. PubMed ID: 38395266
[TBL] [Abstract][Full Text] [Related]
46. Old drugs, new uses: Drug repurposing in hematological malignancies.
Kale VP; Habib H; Chitren R; Patel M; Pramanik KC; Jonnalagadda SC; Challagundla K; Pandey MK
Semin Cancer Biol; 2021 Jan; 68():242-248. PubMed ID: 32151704
[TBL] [Abstract][Full Text] [Related]
47. Dual pharmacological properties of a cyclic AMP-sensitive potassium channel.
Gomora JC; Enyeart JJ
J Pharmacol Exp Ther; 1999 Jul; 290(1):266-75. PubMed ID: 10381786
[TBL] [Abstract][Full Text] [Related]
48. Rational drug repurposing for cancer by inclusion of the unbiased molecular dynamics simulation in the structure-based virtual screening approach: Challenges and breakthroughs.
Sohraby F; Aryapour H
Semin Cancer Biol; 2021 Jan; 68():249-257. PubMed ID: 32360530
[TBL] [Abstract][Full Text] [Related]
49. Cytotoxic effects of antipsychotic drugs implicate cholesterol homeostasis as a novel chemotherapeutic target.
Wiklund ED; Catts VS; Catts SV; Ng TF; Whitaker NJ; Brown AJ; Lutze-Mann LH
Int J Cancer; 2010 Jan; 126(1):28-40. PubMed ID: 19662652
[TBL] [Abstract][Full Text] [Related]
50. Tackling the Behavior of Cancer Cells: Molecular Bases for Repurposing Antipsychotic Drugs in the Treatment of Glioblastoma.
Persico M; Abbruzzese C; Matteoni S; Matarrese P; Campana AM; Villani V; Pace A; Paggi MG
Cells; 2022 Jan; 11(2):. PubMed ID: 35053377
[TBL] [Abstract][Full Text] [Related]
51. Turning liabilities into opportunities: Off-target based drug repurposing in cancer.
Palve V; Liao Y; Remsing Rix LL; Rix U
Semin Cancer Biol; 2021 Jan; 68():209-229. PubMed ID: 32044472
[TBL] [Abstract][Full Text] [Related]
52. Drug Repurposing Approach Identifies a Synergistic Drug Combination of an Antifungal Agent and an Experimental Organometallic Drug for Melanoma Treatment.
Riedel T; Demaria O; Zava O; Joncic A; Gilliet M; Dyson PJ
Mol Pharm; 2018 Jan; 15(1):116-126. PubMed ID: 29185769
[TBL] [Abstract][Full Text] [Related]
53. The anti-psychotic drug pimozide is a novel chemotherapeutic for breast cancer.
Dakir el-H; Pickard A; Srivastava K; McCrudden CM; Gross SR; Lloyd S; Zhang SD; Margariti A; Morgan R; Rudland PS; El-Tanani M
Oncotarget; 2018 Oct; 9(79):34889-34910. PubMed ID: 30405882
[TBL] [Abstract][Full Text] [Related]
54. Repositioning of amprenavir as a novel extracellular signal-regulated kinase-2 inhibitor and apoptosis inducer in MCF-7 human breast cancer.
Jiang W; Li X; Li T; Wang H; Shi W; Qi P; Li C; Chen J; Bao J; Huang G; Wang Y
Int J Oncol; 2017 Mar; 50(3):823-834. PubMed ID: 28197631
[TBL] [Abstract][Full Text] [Related]
55. Drug repurposing a compelling cancer strategy with bottomless opportunities: Recent advancements in computational methods and molecular mechanisms.
Dash R; Yadav M; Biswal J; Samanta S; Sharma T; Mohapatra S
Indian J Pharmacol; 2023; 55(5):322-331. PubMed ID: 37929411
[TBL] [Abstract][Full Text] [Related]
56. Drug repositioning in cancer: The current situation in Japan.
Masuda T; Tsuruda Y; Matsumoto Y; Uchida H; Nakayama KI; Mimori K
Cancer Sci; 2020 Apr; 111(4):1039-1046. PubMed ID: 31957175
[TBL] [Abstract][Full Text] [Related]
57. Drug Repurposing in Anticancer Reagent Development.
Chen PC; Liu X; Lin Y
Comb Chem High Throughput Screen; 2017; 20(5):395-402. PubMed ID: 28025934
[TBL] [Abstract][Full Text] [Related]
58. Repurposing old drugs as new inhibitors of the ubiquitin-proteasome pathway for cancer treatment.
Yang H; Chen X; Li K; Cheaito H; Yang Q; Wu G; Liu J; Dou QP
Semin Cancer Biol; 2021 Jan; 68():105-122. PubMed ID: 31883910
[TBL] [Abstract][Full Text] [Related]
59. Antidepressants and Antipsychotic Agents as Repurposable Oncological Drug Candidates.
Antoszczak M; Markowska A; Markowska J; Huczyński A
Curr Med Chem; 2021; 28(11):2137-2174. PubMed ID: 32895037
[TBL] [Abstract][Full Text] [Related]
60. The incorporation of butyrophenones and related compounds into a pharmacophore for dopamine D2 antagonists.
Froimowitz M; Cody V
Drug Des Discov; 1997 Aug; 15(2):63-81. PubMed ID: 9342550
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
